MED23 and neoplasm: We thus propose the following model: MED23 may control immunogenicity, as MED23 deletion causes low levels of the MHC-I complex accompanied by low levels of CD8+ T lymphocytes, cytokines, chemokines and PD1, which formed a noninflamed (or cold) tumor microenvironment to promote tumorigenesis.